Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Pharyngeal Mucosal Conditioning to Prevent Postoperative Sore Throat in Septoplasty Patients with Severe Nasal Obstruction

Official title: Multimodal Pharyngeal Mucosal Conditioning Versus Standard Care for Prevention of Postoperative Sore Throat in Septoplasty Patients With Severe Preoperative Nasal Obstruction: A Double-Blind Randomized Controlled Trial

Run by Mansoura University · NCT07870252 · Data updated 2026-11-12

This trial tests whether preoperative nebulized saline and a lubricating gel on the breathing tube can lower sore throat after septoplasty in patients with severe nasal blockage.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment105 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Buraidah, Al-Qassim Region)
StatusRecruiting
StartedOctober 15, 2026
Main results expectedApril 15, 2027
Study endsApril 30, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07870252 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-60 with NOSE score ≥55 undergoing elective septoplasty ± turbinoplasty and meeting ASA I-II criteria.

Probably not a fit

Patients without severe nasal obstruction (NOSE <55), those with certain exclusions (e.g., smoking, GERD/LPR, active URIs) or airway challenges may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind study enrolling adults with severe nasal obstruction undergoing septoplasty. It compares preoperative nebulized saline plus endotracheal tube lubrication versus sham nebulization with plain lubrication to see if POST is reduced. All participants receive a standardized anesthesia protocol and throat care, with outcomes focused on the incidence and severity of postoperative sore throat. The study targets patients with NOSE scores ≥55 to identify a high-risk subgroup for POST and to explore a simple, low-cost mucosal conditioning approach. Primary results will inform whether this conditioning strategy should be adopted more broadly in nasal obstruction patients undergoing airway instrumentation.

Why it matters

Potential benefit: If successful, patients could experience fewer and milder sore throats after septoplasty, potentially improving recovery and comfort.

How similar studies have gone: Prior POST prevention work has shown mixed results; this is among the first to target mucosal conditioning specifically in chronic mouth-breathers with severe obstruction.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 60 years
* ASA physical status I or II
* NOSE score ≥55 (severe or extreme nasal obstruction category) at preoperative assessment
* Duration of nasal obstruction symptoms ≥6 months
* Scheduled for elective septoplasty ± turbinoplasty under general anesthesia with endotracheal intubation
* Mallampati class I or II
* BMI ≤35 kg/m²
* Written informed consent obtained

Exclusion Criteria:

* Current or past smoker (any amount)
* Gastroesophageal reflux disease (GERD) or laryngopharyngeal reflux (LPR)
* Known pharyngeal or laryngeal pathology
* Active upper respiratory tract infection within 2 weeks of scheduled surgery
* Preoperative sore throat or baseline pharyngeal pain at time of assessment
* Anticipated difficult airway (Mallampati class III-IV, mouth opening less than 3 cm)
* ACE inhibitor use (causes dry cough, confounds POST assessment)
* Concurrent tonsillectomy, adenoidectomy, or rhinoplasty extending operative time beyond 90 minutes
* Known allergy to lubricant gel components
* Severe systemic disease affecting mucosal hydration (Sjögren's syndrome, uncontrolled diabetes mellitus, end-stage renal disease)
* Pregnancy or breastfeeding
* Previous participation in this study

Where it's running

  • Qassim University Medical City
    Buraidah, Al-Qassim Region, Saudi Arabia
    Recruiting

Study contacts

  • Principal investigator: Mohamed Ahmed Tolba, MD — Mansoura University - Qassim University Medical City
  • Study coordinator: Mohamed Ahmed Tolba, MD
  • Email: m_atolba1234@mans.edu.eg
  • Phone: 00966507439018

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.